Umer Raffat

COVID antiviral Paxlovid to see price increase following 400% vaccine hike Ars Technica
Brigham City
TLisa Jarvis: Five key questions about Medicare’s new drug pricing twincities.com
Rome
HStudies Suggest Pfizer Shot May Protect Only Partially Against Omicron hamodia.com
United States , Japan , Africa , University Hospital , South Africa
New Alzheimer’s treatment Aduhelm may be too costly for many seniors, deepening inequities Merced Sun-Star
Philadelphia , Cambridge
MBiogen’s Alzheimer’s Drug May Price Medicare Billions of {Dollars} Yearly: Report mvtelegraph.com
Wall Street , Massachusetts , Cambridge
MBiogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK4 min marketwatch.com
Merck Names 30-Year Company Veteran as CFO wsj.com
Pfizer expects $20b in COVID-19 vaccine revenue this year Sydney Morning Herald
Australia , Wall Street , Germany , New York , Norway
Historic vaccine race meets harsh reality POLITICO
New York , Midtown
BInvestors Are Betting Big on a Covid-19 Vaccine. Is That Safe?barrons.com
Switzerland , Betting
MA new batch of data for Gilead Sciences’ remdesivir points to efficacy but it’s no ‘silver bullet’marketwatch.com
Gilead says drug helped moderately ill coronavirus patients pressherald.com
Minneapolis , United States , Japan , California
Gilead stock drops amid mixed results on drug remdesivir’s effects on virus timesofisrael.com
Minneapolis , California , Foster City , United States , Japan
MCoronavirus update: Global case tally tops 6 million as weekend protests spark concerns they will lead to an increase in infections marketwatch.com
BChinese Covid-19 Vaccine Trial Results Are a Good Sign For J&J and AstraZeneca’s Efforts barrons.com
Russia , India , Phase 2 , Phase 1 , China
Investors Search for Promising Covid Cures Forbes
North America , Europe , France , Athens , Massachusetts
BPfizer and Merck Earnings Were Good but Their Stocks Diverge barrons.com
Americas
Stocks are soaring on a potential coronavirus treatment. But it's not a silver bullet CNN
Main Street , Wall Street , Chicago , New York

Frequent names

Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.